Literature DB >> 23045434

High phosphate feeding promotes mineral and bone abnormalities in mice with chronic kidney disease.

Wei Ling Lau1, Michael Linnes, Emily Y Chu, Brian L Foster, Bryan A Bartley, Martha J Somerman, Cecilia M Giachelli.   

Abstract

BACKGROUND: Chronic kidney disease-mineral bone disorder (CKD-MBD) is a systemic syndrome characterized by imbalances in mineral homeostasis, renal osteodystrophy (ROD) and ectopic calcification. The mechanisms underlying this syndrome in individuals with chronic kidney disease (CKD) are not yet clear.
METHODS: We examined the effect of normal phosphate (NP) or high phosphate (HP) feeding in the setting of CKD on bone pathology, serum biochemistry and vascular calcification in calcification-prone dilute brown non-agouti (DBA/2) mice.
RESULTS: In both NP and HP-fed CKD mice, elevated serum parathyroid hormone and alkaline phosphatase (ALP) levels were observed, but serum phosphorus levels were equivalent compared with sham controls. CKD mice on NP diet showed trabecular alterations in the long bone consistent with high-turnover ROD, including increased trabecular number with abundant osteoblasts and osteoclasts. Despite trabecular bone and serum biochemical changes, CKD/NP mice did not develop vascular calcification. In contrast, CKD/HP mice developed arterial medial calcification (AMC), more severe trabecular bone alterations and cortical bone abnormalities that included decreased cortical thickness and density, and increased cortical porosity. Cortical bone porosity and trabecular number strongly correlated with the degree of aortic calcification.
CONCLUSIONS: HP feeding was required to induce the full spectrum of CKD-MBD symptoms in CKD mice.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23045434      PMCID: PMC3539425          DOI: 10.1093/ndt/gfs333

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  51 in total

1.  Characterization of a mouse model of chronic uremia.

Authors:  R F Gagnon; B Gallimore
Journal:  Urol Res       Date:  1988

2.  Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study.

Authors:  G A Block; T E Hulbert-Shearon; N W Levin; F K Port
Journal:  Am J Kidney Dis       Date:  1998-04       Impact factor: 8.860

3.  A locus on chromosome 7 determines myocardial cell necrosis and calcification (dystrophic cardiac calcinosis) in mice.

Authors:  B T Ivandic; J H Qiao; D Machleder; F Liao; T A Drake; A J Lusis
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

Review 4.  Osteoporosis and chronic kidney disease.

Authors:  Catherine Stehman-Breen
Journal:  Semin Nephrol       Date:  2004-01       Impact factor: 5.299

5.  The influence of dietary phosphorus and magnesium concentrations on the calcium content of heart and kidneys of DBA/2 and NMRI mice.

Authors:  F A van den Broek; A C Beynen
Journal:  Lab Anim       Date:  1998-10       Impact factor: 2.471

6.  Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure.

Authors:  Jun Oh; Rainer Wunsch; Martin Turzer; Malte Bahner; Paolo Raggi; Uwe Querfeld; Otto Mehls; Franz Schaefer
Journal:  Circulation       Date:  2002-07-02       Impact factor: 29.690

7.  Dystrophic cardiac calcinosis in mice: genetic, hormonal, and dietary influences.

Authors:  G J Eaton; R P Custer; F N Johnson; K T Stabenow
Journal:  Am J Pathol       Date:  1978-01       Impact factor: 4.307

8.  PTH differentially regulates expression of RANKL and OPG.

Authors:  John C Huang; Takeshi Sakata; Laura L Pfleger; Margaret Bencsik; Bernard P Halloran; Daniel D Bikle; Robert A Nissenson
Journal:  J Bone Miner Res       Date:  2003-12-16       Impact factor: 6.741

9.  Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients.

Authors:  Glenn M Chertow; Steven K Burke; Paolo Raggi
Journal:  Kidney Int       Date:  2002-07       Impact factor: 10.612

10.  Successful treatment of an adynamic bone disorder with bone morphogenetic protein-7 in a renal ablation model.

Authors:  Richard J Lund; Matthew R Davies; Alex J Brown; Keith A Hruska
Journal:  J Am Soc Nephrol       Date:  2004-02       Impact factor: 10.121

View more
  25 in total

Review 1.  Molecular Mechanisms of Vascular Calcification in Chronic Kidney Disease: The Link between Bone and the Vasculature.

Authors:  Chang Hyun Byon; Yabing Chen
Journal:  Curr Osteoporos Rep       Date:  2015-08       Impact factor: 5.096

Review 2.  Vascular calcification in CKD-MBD: Roles for phosphate, FGF23, and Klotho.

Authors:  Shunsuke Yamada; Cecilia M Giachelli
Journal:  Bone       Date:  2016-11-12       Impact factor: 4.398

3.  Renal involvement in the pathogenesis of mineral and bone disorder in dystrophin-deficient mdx mouse.

Authors:  Eiji Wada; Takayuki Hamano; Isao Matsui; Mizuko Yoshida; Yukiko K Hayashi; Ryoichi Matsuda
Journal:  J Physiol Sci       Date:  2019-05-11       Impact factor: 2.781

4.  Effect of variations in dietary Pi intake on intestinal Pi transporters (NaPi-IIb, PiT-1, and PiT-2) and phosphate-regulating factors (PTH, FGF-23, and MEPE).

Authors:  Tatiana Martins Aniteli; Flávia Ramos de Siqueira; Luciene Machado Dos Reis; Wagner Vasques Dominguez; Elizabeth Maria Costa de Oliveira; Patrícia Castelucci; Rosa Maria Affonso Moysés; Vanda Jorgetti
Journal:  Pflugers Arch       Date:  2018-01-25       Impact factor: 3.657

5.  Effect of cross-linked chitosan iron (III) on vascular calcification in uremic rats.

Authors:  Barbara Bruna Abreu de Castro; Wander Barros do Carmo; Paulo Giovani de Albuquerque Suassuna; Moises Carminatti; Julia Bianchi Brito; Wagner Vasques Dominguez; Ivone Braga de Oliveira; Vanda Jorgetti; Melani Ribeiro Custodio; Helady Sanders-Pinheiro
Journal:  Exp Biol Med (Maywood)       Date:  2018-05

6.  Aldosterone Is Positively Associated With Circulating FGF23 Levels in Chronic Kidney Disease Across Four Species, and May Drive FGF23 Secretion Directly.

Authors:  Judith Radloff; Maximilian Pagitz; Olena Andrukhova; Rainer Oberbauer; Iwan A Burgener; Reinhold G Erben
Journal:  Front Physiol       Date:  2021-04-29       Impact factor: 4.566

7.  Protective Roles of Xenotropic and Polytropic Retrovirus Receptor 1 (XPR1) in Uremic Vascular Calcification.

Authors:  Hokuto Arase; Shunsuke Yamada; Kumiko Torisu; Masanori Tokumoto; Masatomo Taniguchi; Kazuhiko Tsuruya; Toshiaki Nakano; Takanari Kitazono
Journal:  Calcif Tissue Int       Date:  2022-02-02       Impact factor: 4.333

Review 8.  Cerebral Blood Flow in Chronic Kidney Disease.

Authors:  Bernard Choi; Christian Crouzet; Wei Ling Lau; David H Cribbs; Mark J Fisher
Journal:  J Stroke Cerebrovasc Dis       Date:  2021-03-11       Impact factor: 2.677

Review 9.  Uremic Toxins and Cardiovascular Risk in Chronic Kidney Disease: What Have We Learned Recently beyond the Past Findings?

Authors:  Carolla El Chamieh; Sophie Liabeuf; Ziad Massy
Journal:  Toxins (Basel)       Date:  2022-04-14       Impact factor: 5.075

10.  A phosphate and calcium-enriched diet promotes progression of 5/6-nephrectomy-induced chronic kidney disease in C57BL/6 mice.

Authors:  J Radloff; N Latic; U Pfeiffenberger; C Schüler; S Tangermann; L Kenner; R G Erben
Journal:  Sci Rep       Date:  2021-07-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.